The invention, in one aspect, generally relates to mithramycin derivatives
from mutated Streptomyces argillaceous and their production. The
invention also relates using the derivatives for the treatment of various
diseases. Finally, the invention relates to a mutated Streptomyces
argillaceous useful in the production of the mithramycin derivatives.